Elicio Therapeutics Inc (ELTX) Hedge Fund Ownership (Q2 2026)

Elicio Therapeutics Inc (ELTX)

48 + Investors. Track Smart Money conviction in ELTX. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ELTX

Based on 55 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q

For 4 consecutive quarters, more hedge funds added ELTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

55 hedge funds hold ELTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +139% more funds vs a year ago

fund count last 6Q

+32 new funds entered over the past year (+139% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 62% buying

46 buying28 selling

Last quarter: 46 funds were net buyers (30 opened a brand new position + 16 added to an existing one). Only 28 were sellers (6 trimmed + 22 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+12 vs last Q)

new funds entering per quarter

Funds opening a new ELTX position: 11 → 14 → 18 → 30. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 55% entered in last year

■ 18% conviction (2yr+) ■ 27% medium ■ 55% new

Only 10 funds (18%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares +85%, value -32%

Value

-32%

+85%

Last quarter: funds added +85% more shares while total portfolio value only changed -32%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

🚀

Acceleration phase — new buyers rushing in

5 → 11 → 14 → 18 → 30 new funds/Q

New funds entering each quarter: 11 → 14 → 18 → 30. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 62% of holders entered in last year

■ 20% veterans ■ 18% 1-2yr ■ 62% new

Of 65 current holders: 40 (62%) entered in the past year, only 13 (20%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

🏆

Elite ownership — 42% AUM from top-100 funds

42% from top-100 AUM funds

20 of 48 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in ELTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

5.7

out of 10

Moderate Exit Risk

Exit risk score 5.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	48	47	2.13%
13F Shares	6M	3M	85.45%
Total Value	$23M	$33M	-32.26%
New Positions	30	18	+12
Increased Positions	15	14	+1
Closed Positions	22	10	+12
Reduced Positions	4	6	-2
Total Calls	9	3	200.0%
Total Puts	8	4	100.0%
PUT/CALL Ratio	0.89	1.33	Neutral

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

2.13%

13F Shares

85.45%

Total Value

$23M

$33M

-32.26%

New Positions

+12

Increased Positions

Closed Positions

+12

Reduced Positions

-2

Total Calls

200.0%

Total Puts

100.0%

PUT/CALL Ratio

0.89

1.33

Neutral

Institutional Holders (2026 Q2)

48 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ELTX. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ELTX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Knoll Capital Management, LLC	2.64%	1,211,957	$4.7M
2	Diadema Partners LP	0.06%	112,100	$438K
3	Diadema Partners LP	0.05%	100,000	$391K
4	Ikarian Capital, LLC	0.05%	107,100	$419K
5	Ikarian Capital, LLC	0.05%	107,100	$419K
6	Ikarian Capital, LLC	0.04%	100,000	$391K
7	Caption Management, LLC	0.01%	418,100	$1.6M
8	Mayflower Financial Advisors, LLC	0.00%	10,000	$39K
9	Caption Management, LLC	0.00%	165,700	$648K
10	Leonteq Securities AG	0.00%	20,000	$78K
11	Moody Lynn Lieberson & Walker, LLC	0.00%	10,000	$39K
12	Boothbay Fund Management, LLC	0.00%	32,400	$127K
13	Boothbay Fund Management, LLC	0.00%	32,400	$127K
14	Boothbay Fund Management, LLC	0.00%	30,690	$120K
15	Meyer Handelman Co	0.00%	13,899	$54K
16	Toronto Dominion Bank	0.00%	200,000	$782K
17	Tower Research Capital LLC (TRC)	0.00%	5,286	$21K
18	Summit Financial, LLC	0.00%	10,005	$39K
19	Persistent Asset Partners Ltd	0.00%	286	—
20	HB Wealth Management, LLC	0.00%	10,463	$41K
21	&Partners	0.00%	10,000	$39K
22	Ameritas Investment Partners, Inc.	0.00%	1,176	$5K
23	Alliancebernstein L.P.	0.00%	81,280	$318K
24	Vanguard Fiduciary Trust Co	0.00%	88,062	$344K
25	New York State Common Retirement Fund	0.00%	14,200	$56K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Elicio Therapeutics Inc (ELTX)

What does the Smart Money Trend signal show for ELTX?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added ELTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ELTX?

More buyers than sellers — 62% buying: Last quarter: 46 funds were net buyers (30 opened a brand new position + 16 added to an existing one). Only 28 were sellers (6 trimmed + 22 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ELTX holders?

Elite ownership — 42% AUM from top-100 funds: 20 of 48 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in ELTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ELTX?

Mostly new holders — 55% entered in last year: Only 10 funds (18%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Elicio Therapeutics Inc (ELTX)

Smart Money Signals — ELTX

Buying streak — 4 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +139% more funds vs a year ago

More buyers than sellers — 62% buying

More new buyers each quarter (+12 vs last Q)

Mostly new holders — 55% entered in last year

Buying through price weakness — shares +85%, value -32%

Acceleration phase — new buyers rushing in

Early stage — 62% of holders entered in last year

Elite ownership — 42% AUM from top-100 funds

Institutional Sentiment Summary — ELTX

Hedge Fund Ownership: ELTX

Market Analysis: ELTX

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ELTX

Hedge Fund Positioning: ELTX

Statistics: ELTX

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Elicio Therapeutics Inc (ELTX)

Welcome to 13Foresight!